SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-22-013084
Filing Date
2022-07-28
Accepted
2022-07-28 07:36:44
Documents
5
Period of Report
2022-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp177641_6k.htm 6-K 11549
2 EXHIBIT 99.1 dp177641_ex9901.htm EX-99.1 235765
3 EXHIBIT 99.2 dp177641_ex9902.htm EX-99.2 161570
4 EXHIBIT 99.3 dp177641_ex9903.htm EX-99.3 102495
5 GRAPHIC image_001.jpg GRAPHIC 53376
  Complete submission text file 0000950103-22-013084.txt   585901
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 221112830
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences